Literature DB >> 11231205

Death and dying abroad: the Canadian experience.

D W MacPherson 1, F Guérillot, D L Streiner, K Ahmed, B D Gushulak, G Pardy.   

Abstract

BACKGROUND: The objective was to examine the characteristics of international travelers from Canada, who have died while abroad, and to review the health protection and promotion strategies for prevention of adverse health outcomes associated with travel, which may have prevented these deaths.
METHOD: An EpiInfo 6 program was created to analyse all of the Consular reports received in 1995 via the Secure Integrated Global Network, which provides communications and computerization services to the Department of Foreign Affairs and International Trade, Canada. The Consular Management and Operations System was designed to support the delivery of consular services by the Department, and to link Headquarters in Ottawa with missions in other countries, through case management files, including a "Death Abroad" file. The type of data collected included personal demographics (age, gender), date, country, and cause of death.
RESULTS: In 1995, consular services received 309 reports of Canadians dying abroad. Two hundred and twenty deaths were males (71.2%), and 69 were females (22.3%). The average age (56 years) and median age (43 years) were similar for males and females (age range 0.3-86 years). Recorded causes of death were: natural (62.1%), accidents (24.9%), murder (7.8%), and suicide (5.2%). Cardiovascular disease and trauma were the two most commonly specified causes of death.
CONCLUSIONS: At least 36% of the deaths occurring in Canadian travelers would be considered preventable. Pretravel medical interventions for travelers with known preexisting medical problems, may have prevented many more deaths. International travelers need to be aware of the health risks associated with travel. Access to appropriate health risk assessment, prior to exposure, in many cases, would have prevented death abroad.

Entities:  

Mesh:

Year:  2000        PMID: 11231205     DOI: 10.2310/7060.2000.00070

Source DB:  PubMed          Journal:  J Travel Med        ISSN: 1195-1982            Impact factor:   8.490


  9 in total

1.  Antibiotics for Travelers: What's Good and What's Not.

Authors:  Kathryn N. Suh; Jay S. Keystone
Journal:  Curr Infect Dis Rep       Date:  2004-02       Impact factor: 3.725

2.  Tropical travel and life-threatening disease: preventing malaria misadventures.

Authors:  Anne E McCarthy
Journal:  Can J Infect Dis       Date:  2003-05

3.  Pharmaceutical care model to assess the medication-related risks of travel.

Authors:  Ian M Heslop; Michelle Bellingan; Richard Speare; Beverley D Glass
Journal:  Int J Clin Pharm       Date:  2014-10-01

4.  Statement on Risk of Injury and Travel: Committee to Advise on Tropical Medicine and Travel.

Authors:  A Pozgay
Journal:  Can Commun Dis Rep       Date:  2010-10-17

5.  STATEMENT ON PEDIATRIC TRAVELLERS: Committee to Advise on Tropical Medicine and Travel.

Authors:  S Kuhn; C Hui
Journal:  Can Commun Dis Rep       Date:  2010-06-10

6.  Epidemiological and clinical profile of Korean travelers receiving international medical repatriation.

Authors:  Jiena Kim; Hyo Jeong Choi; Ho Jung Kim
Journal:  Medicine (Baltimore)       Date:  2019-09       Impact factor: 1.817

7.  Croatia is a safe tourist destination - study of foreign citizen mortality in Splitsko-dalmatinska and Primorsko-goranska County during the period 2001-2010.

Authors:  Kristijan Bečić; Darija Jandrić Bečić; Morana Čengija; Goran Ćurić; Antonio Alujević; Marija Definis-Gojanović
Journal:  Croat Med J       Date:  2013-06       Impact factor: 1.351

Review 8.  Pharmacy travel health services: current perspectives and future prospects.

Authors:  Sherilyn Kd Houle
Journal:  Integr Pharm Res Pract       Date:  2018-03-23

9.  Pneumonia among travelers returning from abroad.

Authors:  Séverine Ansart; Olivier Pajot; Jean-Philippe Grivois; Valérie Zeller; Elise Klement; Lucia Perez; Philippe Bossi; François Bricaire; Eric Caumes
Journal:  J Travel Med       Date:  2004 Mar-Apr       Impact factor: 8.490

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.